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Abstract
In recent decades, surgical treatment of hilar cholangiocarcinoma has moved toward liver surgery in association with biliary
resection in order to increase radicality and to achieve better survival. Results of local resection compared with hepatectomy
associated with bile duct resection and its actual indications have to be clarified. A systematic review of relevant studies
published before December 2007 was performed. Original published studies comparing the results of isolated local excision
with those of hepatectomy associated with bile duct resection were identified and the reported results were synthesized. The
pathologic data suggest that isolated bile duct resection cannot be adequate: required wide surgical margins; neoplastic
extension along perineural sheaths; Segment 1 neoplastic invasion. Considering postoperative outcomes, in the 1990s, local
resection had significantly lower mortality rates than liver resection. In recent years, the short-term results of liver surgery
have improved significantly, while mortality rates have decreased. The R0 resection rate is significantly higher after
associated liver resection. Comparison of survival results between local resection and associated liver surgery is difficult
because, in the majority of series, the treatment was planned according to tumor extension. Better long-term outcomes have
been reported after liver resection than after isolated bile duct resection, even for Bismuth-Corlette type III
cholangiocarcinoma. Long-term survivors after local resection have been reported in a few selected patients with
BismuthCorlette type I Tis-T1 or papillary neoplasm.
Introduction
The surgical treatment of hilar cholangiocarcinoma
has changed completely in recent decades: before
1980, the majority of patients were not resected, and
in a few cases local excision of the tumor was
performed with low radicality and poor long-term
outcome. Since 1980, indications for resection have
progressively improved and liver resection has been
associated with bile duct resection in order to increase
radicality and achieve better survival results [14].
Now, local resection seems to have a very narrow role,
but its results compared with those of hepatectomy
associated with bile duct resection and its actual
indications have to be clarified. We have tried to
answer these questions in this systematic review of the
literature.
Methods
Original published studies were identified by search-
ing the MEDLINE database (up to December 2007).
Articles were selected using the key words ‘cholangio-
carcinoma’, ‘local resection’, ‘hepatic resection’, ‘sur-
gery’ to identify all reports that could pertain to
surgical management of hilar cholangiocarcinoma.
Manual cross-referencing was performed and relevant
references from selected articles were reviewed.
Results
No randomized trials are available. All the data were
collected from retrospective studies and from a few
recent prospective studies, including a small number
of patients. Many pathologic data suggest that isolated
bile duct resection is inadequate in the treatment of
Klatskin tumor. Cholangiocarcinoma is an aggressive
neoplasm: extension along the perineural sheath and
associated lymphangiosis carcinomatosa are common
[5,6]. The definition of ‘‘early bile duct cancer’’ is not
widely accepted because in the bile duct the sub-
mucosal layer is thin and often lacking, and the
muscularis mucosae is absent; even small tumors
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may behave in an aggressive and invasive pattern [7].
In 1999, Kayahara reported neural invasion in no
patients with mucosal tumor (Tis) and in 33% of
patients with T1 tumor [6]. In 2002, Ebata reported
that cholangiocarcinoma had both superficial and
intramural extension; to remove invasive neoplasm a
10 mm margin was necessary and 20 mm in the case
of all non-invasive components [8]. These wide
margins can be achieved only by liver resection
when cholangiocarcinoma involves right or left hepa-
tic ducts. Moreover, Sg1 is often invaded by the
tumor; a high rate of tumor recurrence into Sg1 has
been reported after isolated bile duct resection [2,9
13]. Sg1 may be involved by its bile ducts invasion,
direct infiltration or perineural extension [2,913]. In
order to compare isolated local resection with bile
duct excision associated with liver resection, three
topics have to be discussed: short-term outcomes,
radicality, and survival (Table I).
Short-term outcomes
Local resection has been widely considered as safer
than liver resection and with lower mortality rates
[1416]. In 1990, Boerma reviewed published papers
and collected 581 patients undergoing resection for
Klatskin tumor: considering the most relevant series,
mortality was significantly lower after bile duct resec-
tion than after hepatectomy (8% vs 15%) [17]. These
data were confirmed in the 1990s: in 1992, Blum-
gart’s group reported no mortality and 25% morbidity
after local excision compared with 8% and 36%,
respectively, after extended procedures [18]; in 1996,
Pichlmayr reported mortality rates of 12.7% after liver
surgery associated with bile duct resection vs 3.3%
after local excision [15]. The increased mortality rate
after liver resection was considered a clear indication
of local resection: even though associated liver surgery
could improve radicality, long-term benefits were lost
because of high mortality rates [14].
In 2000, Launois published different results: in this
French survey, mortality rates were high but similar in
patients with and without liver resection (17% vs
14%) [19]. Postoperative outcomes of liver surgery
have improved significantly in recent years, thanks to
better patient selection, preoperative biliary drainage,
and portal vein embolization [2023]. In 2000, Tsao
compared the results of surgical treatment in a
Japanese center (Nagoya), where liver resection was
performed routinely, with those of an American
center (Lahey clinic), where isolated bile duct resec-
tion was preferred: short-term outcomes were good
and similar between the two groups, i.e. 4% vs 8%
mortality and 44% vs 51% morbidity [24]. In 2002,
our group published an article on 36 patients resected
for hilar cholangiocarcinoma, and with associated
liver resection in 32 (88.9%): mortality and morbidity
rates were 2.8% and 47.2%, respectively [25]. Some
recent articles by oriental groups have reported no
mortality after bile duct resection associated with
hepatectomy [20,22,23].
Radicality
According to the pathologic characteristics of Klatskin
tumor, local excision is inadequate for radical resec-
tion. This has been confirmed in surgical series: the
rate of radical resections has increased along with
the rate of associated liver resections [1]. R0 resection
rates ranged from 15% in Cameron’s series with 20%
hepatectomy to 56% in Blumgart’s series with 60%
liver resections, reaching 80% when liver resection
was associated in about 80% of cases [2629].
Nimura performed liver resection in 98% of cases,
with a radicality rate of 83% [11]. Our center had
similar results: liver resections in 89% of patients and
a radicality rate of 89% [25]. Many studies have
reported that R0 resections are significantly less
common after local excision than after bile duct
resection associated with liver surgery [3,5,16,30].
In 2000, Tsao compared between the results of
Klatskin tumor resection at Nagoya University and
the Lahey Clinic: the first center performed liver
resection in 89% of cases and R0 resection was
achieved in 79%; the second performed hepatectomy
in only 16% of patients and radicality decreased
significantly to 28% [24]. Liver resection is not always
necessary to reach negative margins: in 2004, Kondo
published a series of 40 consecutive patients with
radical resection, including 9 cases treated by isolated
bile duct resection [23].
Survival
In the majority of published series, no evidence has
been found of any statistical difference in survival
between local resection and extended surgery [2,4,14
16,18,19,3133]. In 1999, Launois published a series
of 40 consecutive resected patients: survival after local
resection was significantly better than after associated
hepatectomy (5-year survival rates 27% vs 6%) [34].
These data could be related to the fact that the
treatment was planned according to tumor location
and that liver resection was scheduled for patients
with more extended disease. In 2000, Tsao, on
comparing oriental and US experiences, reported
significantly better survival in Japanese patients un-
dergoing more aggressive surgical strategy (5- and 10-
year survival rates were 16% and 12% vs 7% and 0%)
[24].
Some studies have reported significantly increased
survival after associated liver resection: 1) In the
Boerma review published in 1990, survival was
significantly lower after local resection than after
extended surgery (5-year survival rate 7% vs 17%)
[17]. 2) In 2001, Jarnagin analyzed 80 consecutive
patients. Five-year survival rates were 37% in patients
with liver resection and 0% in patients without it. In
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Table I. Comparison between local resection (LR) and bile duct resection with associated hepatic resection (HR) in published series.
# Mortality (%) Radicality (%) 5-year survival (%) Median survival (months)
Author Year LR HR LR HR p LR HR p LR HR p LR HR p
Boerma [17] 1990 201 188 80.0 15.0 B0.05 70.0 17.0 B0.05
Bismuth [35] 1992 10 13 0 0 n.s. 30.0 46.1 n.s.
Baer [18] 1992 12 11 0 80.3 n.s. 36 32 n.s.
Pichlmayr [15] 1996 30 95 30.3 12.7 n.s. 28.9 26.3 n.s.
Miyazaki [16] 1998 11 65 0 15.0 n.s. 45.0 75.0 B0.05 16.0
3 yrs
33.0
3 yrs
n.s.
Launois [34] 1999 11 25 0 16.0 n.s. 27.3 60.0 B0.05
Neuhaus [5] 1999 14 66 0 90.1 n.s. 29.0 61.0 B0.05 0 2857* n.s.
Kosuge [32] ** 1999 13 52 70.7 90.6 n.s. 38.5 55.8 n.s. 38.6 27.0 n.s.
Nimura [39] 2000 8 100 0 60.0 n.s. 16.0 26.0 n.s.
Launois [19]
(French survey)
2000 51 47 14.0 17.0 n.s. 23 24 n.s.
Jarnagin [30] 2001 18 62 60.0 11.0 n.s. 56.0 84.0 B0.05 0 37.0 B0.05
Capussotti [25] 2002 4 32 0 30.0 n.s. 75.0 90.6 n.s. 0§ 54.5§ B0.05§
Kondo [23] 2004 9 31 0 0 n.s. 100 100 n.s. 20.8§§ NA§§ B0.05§§
Jang [31] 2005 25 23 0 0 n.s. 28.0 47.8 n.s.
Dinant [3] 2006 60 37 13.1 2617% n.s. 14.8 4237% B0.05 21.5 3869% n.s.
*Different survival rates depending on type of hepatectomy.
**Local resection/limited hepatic resections vs major hepatectomies.
§Only BC III included.
§§Local resection/caudate segmentectomy/left hepatectomy vs right hepatectomy.
%Results after right hepatectomyleft hepatectomy.
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order to exclude the possibility that the difference in
survival was related to radicality rate, the analysis was
repeated including only R0 patients and the result was
confirmed [30]. 3) In 2004, Kondo reported long-
term results in 40 consecutive patients with R0
resection. Nine patients treated by isolated bile duct
resection had significantly decreased survival com-
pared with 17 patients undergoing right hepatectomy
[23].
All these data concern hilar cholangiocarcinoma
with different extension into the bile ducts. Patients
undergoing local resection probably had tumors with
or without minimal involvement of the bile duct
confluence, but this is not clearly defined in the
majority of articles. In order to clarify whether local
resection may have a role in these patients, we focused
our analysis on reported results in BismuthCorlette
(BC) type III hilar cholangiocarcinoma.
Two articles from France suggest that local resec-
tion could be indicated in selected patients [34,35]. In
1992, Bismuth reported 3 patients with BC I tumor
undergoing isolated bile duct resection: 2 cases with
R0 resection had long-term survival without recur-
rence; 1 case with R1 resection had long-term survival
with recurrence and re-resection [35]. In contrast, all
the patients with local resection for BC II tumor had
recurrence. In 1999, Launois reported 4 patients with
BC I (undergoing local resection in 3 cases) and 4
patients with BC II neoplasms (local resection in 3)
[34]. Five-year survival results were good (type I 20%;
type II 25%), similar to those reported for more
extended BC types. Patients with local resection
mainly had Tis and T1 tumors. Two long-term
survivors have been reported: one BC I T1bN0M0
and one BC II TisN0M0.
Different results have recently been published with
poor outcomes. In the Neuhaus series published in
1999, radicality of isolated local resection was 33% (2/
6) in BC I and 25% (1/4) in BC II tumors; among
them, no patient survived 5 years [5]. Similar results
have been reported by Su after local resection in 1996
(25% R0 resection rate for BC I) and by van Gulik in
1999 (19% R0 resection rate for BC III) [36,37]. In
our experience published in 2002, R0 resection was
achieved in 2 out of 3 BC III tumors treated by local
resection, but patient survival was significantly lower
after isolated bile duct resection (3 cases) than after
associated liver resection (6 cases), and no patient
with bile duct resection was alive at 2 years [25].
In 2005, Jang reported 25 patients undergoing
isolated bile duct resection for BC III or common
hepatic duct cancer [31]. Seven patients (28%)
survived 5 years or more, but three of them were
alive with recurrence despite their early stage (T1N0
in 2 and T2N0 in 1).
In Kondo’s series, 9 patients (6 BC I and 3 BC II)
underwent local resection: even though all had radical
resection, their survival rate was significantly lower
than that of patients with associated liver surgery
(median survival 19 vs 21 months) [23]. In 2003,
Makuuchi’s group reported results of systematic liver
resection: mean survival was 42 months in 9 patients
BC I and 51 months in 8 BC II [22].
A recent article by the Nagoya group focused on
54 patients affected by BC type III tumors [38]. In
14 cases, an isolated bile duct resection was per-
formed. Unfortunately, the study analyzed the out-
comes of right hepatectomies with caudate lobectomy
compared with those of more limited resections, and
few data are available on isolated bile duct resection
without hepatectomy. Accordingly, the authors sug-
gested a surgical approach based on cholangiographic
tumor type: extended hepatectomy is always neces-
sary in the event of nodular or infiltrating tumor; on
the contrary, bile duct resection with or without
limited hepatectomy can be adequate in the case of
papillary tumor without superficial cancer spreading.
Regardless, further studies are needed to better define
these indications, mainly because only two patients of
the papillary group have been treated by isolated local
resection.
Consensus statements
Local resection is not an adequate treatment for
hilar cholangiocarcinoma involving the bile duct
confluence; associated liver resection should be re-
commended. In BismuthCorlette type I hilar cholan-
giocarcinoma, benefits of survival by association of
biliary and liver resection have been reported, but
further studies are needed. Local resection should be
scheduled only for small papillary Klatskin tumors
without bile duct confluence involvement (type I)
confined to the bile duct wall (Tis and T1). Extension
of treatment should always be determined in accor-
dance with the patient’s condition.
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